推薦產品
product name
Fmoc-Lys(Alloc)-OH, ≥95.0% (HPLC)
品質等級
化驗
≥95.0% (HPLC)
形狀
powder
光學活性
[α]20/D −12±1°, c = 1% in DMF
反應適用性
reaction type: Fmoc solid-phase peptide synthesis
技術
NMR: suitable
顏色
beige
應用
peptide synthesis
官能基
Fmoc
儲存溫度
2-8°C
SMILES 字串
OC(=O)[C@H](CCCCNC(=O)OCC=C)NC(=O)OCC1c2ccccc2-c3ccccc13
InChI
1S/C25H28N2O6/c1-2-15-32-24(30)26-14-8-7-13-22(23(28)29)27-25(31)33-16-21-19-11-5-3-9-17(19)18-10-4-6-12-20(18)21/h2-6,9-12,21-22H,1,7-8,13-16H2,(H,26,30)(H,27,31)(H,28,29)/t22-/m0/s1
InChI 密鑰
OJBNDXHENJDCBA-QFIPXVFZSA-N
相關類別
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
WGK 3
閃點(°F)
Not applicable
閃點(°C)
Not applicable
個人防護裝備
Eyeshields, Gloves, type N95 (US)
客戶也查看了
ACS applied materials & interfaces, 9(26), 21618-21630 (2017-06-09)
In dentistry and orthopedics, it is well accepted that implant fixation is a major goal. However, an emerging concern is bacterial infection. Infection of metallic implants can be catastrophic and significantly reduce patient quality of life. Accordingly, in this work
Journal of controlled release : official journal of the Controlled Release Society, 305, 210-219 (2019-05-10)
Currently, there are limited treatment options for multi-drug resistant breast cancer. Lipid-modified cationic peptides have the potential to reach the mitochondria, which are attractive targets for the treatment of multi-drug resistant (MDR) breast cancer; yet, little is known about their
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務